BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Forward Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 12:59 pm Sale | 2021-12-31 | 13G | Forward Pharma A/S FWPAY | BIOTECHNOLOGY VALUE FUND L P | 25,239 7.300% | -10,532![]() (-29.44%) | Filing |
2021-02-11 5:18 pm Sale | 2020-12-31 | 13G | Forward Pharma A/S FWPAY | BIOTECHNOLOGY VALUE FUND L P | 35,771 10.700% | -13,677![]() (-27.66%) | Filing |